TBIO

Q: What is the price of Translate Bio (TBIO) today?

The current price of Translate Bio (TBIO) is $0.05. The stock began the year trading around $0.05 and is currently priced at $0.05. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Translate Bio (TBIO) pay dividends?

Translate Bio (TBIO) did not pay dividends over the past year.

Q: Is Translate Bio (TBIO) a good investment?

Translate Bio (TBIO) is currently trading at $0.05 with a P/E ratio of 0.00. This represents a -935% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -83.33%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Translate Bio Inc.

Price

$0.05

return (12m)

-83.33%

p/e

0.00

p/bv

0.01

DIVIDEND YIELD

0.00%

TBIO price

Translate Bio

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment TBIO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-5.66%

3 months

-1.96%

1 year

-83.33%

2 years

-98.68%

5 years

-99.99%

10 years

0.00%

Fundamentals TBIO

review the fundamentals of Translate Bio shares

P/E

0.00

Sector: -4.19 Industry: -4.19

P/S (PSR)

0.01

Sector: -4.12 Industry: -4.12

P/BV

0.01

Sector: 2.03 Industry: 2.03

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-93.97%

Sector: -66.67% Industry: -66.67%

ROE

-497.99%

Sector: -66.75% Industry: -66.75%

ROIC

-100.49%

Sector: -2,914.97% Industry: -2,914.97%

NET MARGIN

-100.00%

Sector: -40.34% Industry: -40.34%

GROSS MARGIN

47.92%

Sector: 36.53% Industry: 36.53%

OPERATING MARGIN

-100.00%

Sector: -39.20% Industry: -39.20%

EV/EBITDA

0.00

Sector: -4.32 Industry: -4.32

EV/EBIT

0.00

Sector: -4.40 Industry: -4.40

PRICE-TO-ASSETS

0.00

Sector: 1.47 Industry: 1.47

BVPS

4.98

Sector: 1.86 Industry: 1.86

EPS

-24.78

Sector: -2.18 Industry: -2.18

EQUITY-TO-ASSETS RATIO

0.19

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.81

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

9.67%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

4.93%

Sector: - Industry: -

Fundamentals TBIO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
TBIO	0.00	0.01	-497.99%	0.00%	$100.00 K	-100.00%
JNJ	30.12	7.81	25.92%	1.99%	$633.66 B	21.83%
PFE	18.48	1.53	8.29%	7.07%	$138.41 B	11.83%
ABBV	127.12	-69.89	-54.98%	2.58%	$462.09 B	5.79%
NVO	11.81	7.13	60.40%	3.69%	$224.06 B	37.15%
MRK	35.84	6.97	19.45%	2.56%	$320.27 B	13.59%
AZN	29.10	6.38	21.93%	1.64%	$302.29 B	17.19%
GILD	17.69	6.96	39.33%	2.45%	$163.04 B	30.99%
BMY	16.28	5.89	36.19%	4.30%	$118.47 B	15.01%
ZTS	11.94	9.76	81.75%	2.75%	$31.57 B	27.79%
REGN	15.38	2.17	14.08%	0.56%	$68.04 B	29.65%
HALO	26.88	42.68	158.82%	0.00%	$9.38 B	23.13%
AMGN	25.90	21.98	84.87%	2.62%	$202.04 B	20.96%
MCK	20.14	-115.02	-570.98%	0.42%	$95.93 B	1.18%
VRTX	30.92	6.93	22.41%	0.00%	$134.12 B	35.51%
CAH	36.11	-21.01	-58.20%	0.85%	$56.15 B	0.62%
HRMY	14.84	2.37	16.00%	0.00%	$2.16 B	16.20%
BIIB	23.16	1.70	7.36%	0.00%	$31.77 B	13.81%
MEDP	33.91	26.09	76.95%	0.00%	$15.61 B	17.19%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TBIO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Translate Bio

Translate Bio Inc.

Average Investor10 user rating

4.0 (0 people)

United States

10 years

Founded: 2016

2018

Time since IPO - 8 years

122

Employees

Translate Bio Inc. (United States) is listed on the Nasdaq and has a market capitalization of $100.00 Thousand, with shareholders equity totaling $9.95 million.

The company employs approximately 122 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Translate Bio Inc. reported $17.53 million in revenue, generating net income of $-49.55 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.01, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TBIO.

Market cap

$100.00 Thousand

Net worth

$9.95 million

$9,950,000.00

Assets

$52.73 million

$52,730,000.00

Total Shares Outstanding

2.00 million

2,000,000

Average Daily Trading Volume

$571.84

Sector

Health Care

Industry

Biotechnology

TBIO

TBIO revenue and profits

Financial Results TBIO

DRAG THE FRAME TO SEE MORE DATA

TBIO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$786.30 9,76% (12M)

P/E

20.14

0.42%

ROE

-570.98%

P/BV

-115.02

CAH - Cardinal Health

$238.94 46,53% (12M)

P/E

36.11

0.85%

ROE

-58.20%

P/BV

-21.01

JNJ - Johnson & Johnson

$263.04 72,84% (12M)

P/E

30.12

1.99%

ROE

25.92%

P/BV

7.81

MRK - Merck & Co.

$129.56 65,87% (12M)

P/E

35.84

2.56%

ROE

19.45%

P/BV

6.97

AZN - AstraZeneca

$195.15 42,59% (12M)

P/E

29.10

1.64%

ROE

21.93%

P/BV

6.38

ABBV - AbbVie

$261.07 43,55% (12M)

P/E

127.12

2.58%

ROE

-54.98%

P/BV

-69.89

NVO - Novo Nordisk

$50.43 --23,73% (12M)

P/E

11.81

3.69%

ROE

60.40%

P/BV

7.13

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$786.30 9,76% (12 M)

P/L

20.14

0.42%

ROE

-570.98%

P/VP

-115.02

CAH - Cardinal Health

$238.94 46,53% (12 M)

P/L

36.11

0.85%

ROE

-58.20%

P/VP

-21.01

JNJ - Johnson & Johnson

$263.04 72,84% (12 M)

P/L

30.12

1.99%

ROE

25.92%

P/VP

7.81

MRK - Merck & Co.

$129.56 65,87% (12 M)

P/L

35.84

2.56%

ROE

19.45%

P/VP

6.97

AZN - AstraZeneca

$195.15 42,59% (12 M)

P/L

29.10

1.64%

ROE

21.93%

P/VP

6.38

ABBV - AbbVie

$261.07 43,55% (12 M)

P/L

127.12

2.58%

ROE

-54.98%

P/VP

-69.89

NVO - Novo Nordisk

$50.43 --23,73% (12 M)

P/L

11.81

3.69%

ROE

60.40%

P/VP

7.13

Frequently Asked Questions

What is the price of Translate Bio (TBIO) today?

The current price of Translate Bio (TBIO) is $0.05. The stock began the year trading around $0.05 and is currently priced at $0.05. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Translate Bio (TBIO) pay dividends?

Translate Bio (TBIO) did not pay dividends over the past year.

Is Translate Bio (TBIO) a good investment?

Translate Bio (TBIO) is currently trading at $0.05 with a P/E ratio of 0.00. This represents a -935% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -83.33%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Translate Bio (TBIO) stock?

You can buy Translate Bio (TBIO) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol TBIO and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Translate Bio (TBIO) yield today?

Over the past month, Translate Bio (TBIO) has returned -5.66% — -83.33% over the past year, and -99.99% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Translate Bio (TBIO) today at the current price of $0.05 your total investment would be $5.00.

Based on historical performance, the investment would have grown to approximately:

$0.83 after 1 year
$0.000500 after 5 years
$5.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

TBIO

Translate Bio Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment TBIO

review the fundamentals of Translate Bio shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Translate Bio

Translate Bio Inc.

United States

10 years

2018

122

PROFIT X PRICE TBIO

Financial Results TBIO

TBIO cash flow

Asset, Revenue and Profit Growth - TBIO

TBIO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions